(Q37496102)

20 August 2017

Human insulin does not increase bladder cancer risk (English)

1 reference

20 August 2017

1 reference

1 reference

Chin-Hsiao Tseng

1

0 references

language of work or name

English

0 references

publication date

20 January 2014

1 reference

20 August 2017

1 reference

20 August 2017

9

1 reference

20 August 2017

1

1 reference

20 August 2017

e86517

1 reference

Creative Commons Attribution 4.0 International

20 August 2017

start time

20 January 2014

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Thyroid cancer risk is not increased in diabetic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Risk of bladder cancer among diabetic patients treated with pioglitazone: interim report of a longitudinal cohort study.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Diabetes and risk of bladder cancer: evidence from a case-control study in New England

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Diabetes and cancer: a consensus report.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Bladder cancer in 2010: how far have we come?

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Doses of insulin and its analogues and cancer occurrence in insulin-treated type 2 diabetic patients

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Diabetes mellitus and risk of bladder cancer: a meta-analysis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Taiwan's new national health insurance program: genesis and experience so far.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Peroxisome proliferator-activated receptor agonists and bladder cancer: lessons from animal studies

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Pioglitazone and bladder cancer in human studies: is it diabetes itself, diabetes drugs, flawed analyses or different ethnicities?

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

High dose human insulin and insulin glargine promote T24 bladder cancer cell proliferation via PI3K-independent activation of Akt.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

New-onset diabetes with a history of dyslipidemia predicts pancreatic cancer.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

Urothelial overexpression of insulin-like growth factor-1 increases susceptibility to p-cresidine-induced bladder carcinogenesis in transgenic mice.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3896459

2 September 2018

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0086517

Urinary insulin-like growth factor 2 identifies the presence of urothelial carcinoma of the bladder

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0086517

Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use

21 January 2018

1 reference

12 December 2020

Insulin-induced proliferation of bladder cancer cells is mediated through activation of the epidermal growth factor system

1 reference

12 December 2020

1 reference

12 December 2020

Plasma levels of insulin-like growth factor-1 and binding protein-3, and their association with bladder cancer risk

1 reference

12 December 2020

10.1371/JOURNAL.PONE.0086517

Identifiers

DOI

1 reference

20 August 2017

0 references

1 reference

PMC publication ID

3896459

20 August 2017

PubMed publication ID

24466131

1 reference

PMC publication ID

3896459